MSI-1436C
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MSI-1436C, covering 2018-05-18 to 2018-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer [Phase 1]